Skip to main content

Table 1 Major results of the ALLHAT study

From: Comments on ALLHAT and doxazosin

  Doxazosin Chlorthalidone
Event (%) (%)
Coronary heart disease 6.3 6.3
Stroke 4.2 3.6*
Combined cardiovascular disease 25.5 21.8**
Congestive heart failure 8.1 4.5**
Coronary revascularization 6.2 5.2***
  1. Results are presented as a percentage of those entered in each arm, either doxazosin or chlorthalidone. Data from [1]. *P = 0.04, **P < 0.001, ***P = 0.05.